相关实验视频
Updated: Jun 19, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.0K
生物电阻与人体测量技术之间的关系,以确定黑人儿科人口的身体脂肪
N Kay Covington1, Darlene A Kluka2, Phyllis A Love3
1Dept. of HRPE at Southern Illinois University at Edwardsville, Edwardsville, IL 62026, USA.
Pediatric exercise science
|August 17, 2024
概括
生物电阻分析 (BIA) 可能会高估5-11岁黑人儿童的体脂. 人类测量测量显示出强烈的相关性,但BIA结果高于预期.
科学领域:
- 儿科肥胖症研究的研究.
- 身体组成分析分析.
- 生物医学工程 生物医学工程
背景情况:
- 准确的体脂测量对于儿科健康评估至关重要.
- 生物电阻分析 (BIA) 和人体测量是估计身体脂肪的常见方法.
- 关于不同儿科群体,特别是黑人儿童的BIA准确性的数据有限.
研究的目的:
- 为了比较从黑人儿童的BIA和人类学中得出的身体脂肪百分比估计.
- 评估BIA在这个特定的人口群体中的准确性.
- 为了调查黑人儿科受试者BIA对肥胖的潜在高估.
主要方法:
- 一组196名黑人儿童 (93名女孩,103名男孩,年龄在5-11岁) 参加.
- 使用生物电阻分析仪-103.3测量身体脂肪百分比.
- 人类测量测量 (三头骨,中间小腿) 也被记录下来.
- 数据分析涉及皮尔森相关性和ANOVA来比较BIA和人类学结果.
主要成果:
- 在BIA和人类计量方法之间观察到强烈的整体相关性 (r=.809).
- 生物电阻分析 (BIA) 倾向于高估研究中的黑人儿童的身体脂肪百分比.
- 在模拟学校环境中偏离严格的协议可能影响了结果.
结论:
- 生物电阻分析 (BIA) 可能会高估5-11岁黑人儿童的体脂.
- 人类测量在这个人群中提供了可比的身体脂肪测量.
- 需要进一步的研究来验证BIA在不同的儿科组和各种条件下.
相关概念视频
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...